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traffic regulator for RANKL to LAMP1 + secretory lys-
osomes in osteoblasts and osteocytes, which seem to serve 
as temporary storage compartments for RANKL. Our in 
situ observations indicate that TRAP is located to RANKL-
/OPG-positive secretory lysosomes in osteoblasts and oste-
ocytes, which may have implications for osteocyte regula-
tion of osteoclastogenesis.
Keywords TRAP · RANKL · OPG · LAMP1 · 
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Introduction
Tartrate-resistant acid phosphatase (TRAP) (ACP5, EC 
3.1.3.2) belongs to a group of metalloenzymes, which 
catalyzes hydrolysis of phosphate esters and anhydrides 
under acidic conditions. TRAP is synthesized as a rela-
tively inactive pro-enzyme; monomeric TRAP (mTRAP)/
loop-TRAP/serum TRAP 5a, but proteolytic processing 
of the 5a isoform to generate the “two subunit” cleaved 
TRAP 5b isoform by, e.g., members of the cathepsin fam-
ily or other proteinases, increases the catalytic activity at 
Abstract Tartrate-resistant acid phosphatase (TRAP) 
is well known as an osteoclast marker; however, a recent 
study from our group demonstrated enhanced number of 
TRAP + osteocytes as well as enhanced levels of TRAP 
located to intracellular vesicles in osteoblasts and osteo-
cytes in experimental osteoporosis in rats. Such vesicles 
were especially abundant in osteoblasts and osteocytes in 
cancellous bone as well as close to bone surface and intra-
cortical remodeling sites. To further investigate TRAP in 
osteoblasts and osteocytes, long bones from young, grow-
ing rats were examined. Immunofluorescence confocal 
microscopy displayed co-localization of TRAP with recep-
tor activator of NF-KB ligand (RANKL) and osteoprote-
gerin (OPG) in hypertrophic chondrocytes and diaphyseal 
osteocytes with Pearson’s correlation coefficient ≥0.8. 
Transmission electron microscopy showed co-localization 
of TRAP and RANKL in lysosomal-associated membrane 
protein 1 (LAMP1) + vesicles in osteoblasts and osteo-
cytes supporting the results obtained by confocal micros-
copy. Recent in vitro data have demonstrated OPG as a 
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least tenfold (Fagerlund et al. 2006; Funhoff et al. 2001; 
Lang and Andersson 2005; Ljusberg et al. 1999). The 
isoform TRAP 5b shows different biological abilities in 
bone, e.g., dephosphorylation of osteopontin (OPN) and 
integrin-binding sialoprotein (IBSP) (Ek-Rylander and 
Andersson 2010; Ek-Rylander et al. 1994), dephosphoryla-
tion of Man-6-P recognition marker on lysosomal proteins 
(Bresciani and Von Figura 1996; Sun et al. 2008) and gen-
eration of reactive oxygen species for bone matrix degrada-
tion (Halleen et al. 1999, 2003; Vaaraniemi et al. 2004). On 
the other hand, the monomeric TRAP isoform 5a exhibits 
growth factor-like properties for mesenchymal cells, e.g., 
pre-adipocytes (Lang et al. 2008; Patlaka et al. 2014) and 
pre-osteoblasts (Gradin et al. 2012). TRAP gene expression 
and enzyme activity seems to be most abundant in bone tis-
sue, and young rats express more TRAP mRNA and TRAP 
enzyme activity than adults (Ek-Rylander et al. 1991; Lang 
and Andersson 2005). Halleen and co-workers have shown 
that the serum activity of TRAP 5b is significantly elevated 
in patients with osteoporosis and negatively correlated with 
bone mineral density (BMD) (Halleen et al. 2002). Stud-
ies on mice yielded similar results: Absence of TRAP 
leads to disturbed endochondral ossification and a mild 
osteopetrotic phenotype (Hayman et al. 1996; Suter et al. 
2001), while overexpression of TRAP results in enhanced 
bone turnover and a mild osteoporotic phenotype (Angel 
et al. 2000). TRAP 5b is mainly found in osteoclasts 
and has been advocated as a serum marker for osteoclast 
number. However, also other bone cells express TRAP in 
vivo; hypertrophic chondrocytes in the rat epiphysis (Hes-
sle et al. 2013), osteoblasts in the metaphysis and in the 
endosteal and periosteal compartments of diaphyseal rat 
bone (Bianco et al. 1988; Bonucci et al. 2001; Gradin et al. 
2012; Mocetti et al. 2000; Yamamoto and Nagai 1998) as 
well as osteocytes in cancellous and cortical rat bone near 
bone surface or bone resorption sites (Bianco et al. 1988; 
Nakano et al. 2004). The function of TRAP in these cells 
has been debated and recently increased levels of TRAP 
gene expression and enzyme activity were demonstrated in 
osteocytes with active osteocytic osteolysis (Kogawa et al. 
2013; Qing et al. 2012). However, the direct contribution of 
TRAP to osteocytic osteolysis was not investigated in these 
studies.
The intracellular distribution of TRAP in hypertrophic 
chondrocytes, osteoblasts and osteocytes is only sparsely 
described in the literature; however, TRAP enzyme activ-
ity has been reported in vesicular structures in osteoblasts 
(Bonucci et al. 2001; Yamamoto and Nagai 1998) and 
Reinholt and co-workers demonstrated TRAP + vesicles 
in osteoblast-like cells with immunogold technique (Rein-
holt et al. 1990). Our recent TEM studies on osteoblasts 
and osteocytes revealed TRAP in intracellular electron-
dense vesicles with similar features in the two cell types. 
In addition, there were more TRAP in osteoblasts and 
osteocytes in rats with experimental osteoporosis, how-
ever, without any sign of osteocytic osteolysis. Moreover, 
TRAP + osteocytes were found in close relation to bone 
remodeling surfaces and bone surfaces (Solberg et al. 
2014). This may indicate a role for TRAP in osteocyte-
regulated bone remodeling. To further investigate the role 
of TRAP in osteoblasts and osteocytes, we hypothesized 
that a morphological clarification of the TRAP + vesi-
cles would serve as a starting point for elucidation of the 
function of TRAP in these cells. We therefore performed 
the current study on young, growing rats, to facilitate the 
intracellular immunogold labeling, and observed that the 
TRAP + vesicles in osteoblasts and osteocytes co-labeled 
for receptor activator of NF-KB ligand (RANKL) as well 
as lysosomal-associated membrane protein 1 (LAMP1) in 
the vesicular membrane. We also demonstrated co-localiza-
tions of TRAP with RANKL and osteoprotegerin (OPG) in 
hypertrophic chondrocytes and diaphyseal osteocytes.
Materials and methods
Animals
Guide for the Care and Use of Laboratory Animals (2011) 
was followed and the study protocol approved by the Nor-
wegian National Animal Research Authority. Three days 
old, normal female Wistar rats were killed by a guillotine. 
Their right tibia and femur were immediately dissected 
free and immersed in phosphate-buffered (0.1 M) 4 % 
paraformaldehyde (pH 7.40) and 0.1 % glutaraldehyde for 
immunogold labeling and transmission electron micro-
scopic (TEM) analyses or 4 % formalin for immunofluo-
rescence and confocal microscopy, respectively, and stored 
at room temperature for 24 h. The formalin-fixed femur 
specimens were embedded in paraffin before they were cut 
in 2–3-µm-thick longitudinal sections and mounted on plus 
glass slides.
For immunogold labeling, thawed cryosections were 
used to increase the success rate for intracellular labeling; 
after pre-fixation, the paraformaldehyde/glutaraldehyde-
fixed tibia specimens were cut into small samples and infil-
trated with 2.3 M sucrose over night at 4 °C either directly 
or after an initial infiltration with 10 % gelatin for 1 h at 
37 °C. Infiltration with gelatin was performed to ease ori-
entation and mounting of the specimens. The samples were 
subsequently mounted on silver stubs, frozen and stored 
in liquid nitrogen (LN2). Ultrathin cryosections (75 nm) 
were cut with a cryodiamond knife (Diatome ltd, Biel, 
Switzerland) in a Leica Ultracut EM UC7 ultramicrotome 
equipped with a Leica EM FC7 cryounit (Leica Microsys-
tems AG, Wetzlar, Germany). Sections were picked up 
197Histochem Cell Biol (2015) 143:195–207 
1 3
using 2.3 M sucrose and mounted on formvar-coated cop-
per grids before labeling.
Antibodies
Goat anti-RANKL (SC-7628) and goat anti-OPG (SC-
8468) were purchased from Santa Cruz Biotechnology, 
Inc. (Dallas, Texas, USA). Species anti-LAMP1 (ab24170) 
was from Abcam (Cambridge, UK). Rabbit anti-loop-
TRAP/mTRAP (toward the loop region of uncleaved 
5a isoform), and rabbit anti-m + cTRAP (toward both 
the uncleaved 5a and cleaved 5b isoforms) were from G. 
Anderssons laboratory (Zenger et al. 2010). Rabbit anti-
TRAP (SB-TR103) (toward total TRAP) was purchased 
from Immunodiagnostic Systems Ltd. (Tyne & Wear, 
UK). The two antibodies for TRAP (m + cTRAP from G. 
Anderssons laboratory and total TRAP from Immunodi-
agnostic Systems) demonstrated equal distribution of the 
antibody labeling (data not shown). Single labeling was 
performed for all the different antibodies in order to control 
for cross-reactivity in the double labeling. Alexa Fluor-555 
conjugated donkey anti-rabbit IgG and Alexa Flour-488 
donkey anti-goat IgG as well as DAPI nucleic acid stains 
were from Molecular Probes (Invitrogen Co., Eugene, OR, 
USA). Protein A-coated 5, 10 and 15 nm colloidal gold 
were purchased from G. Posthuma (Utrecht, The Nether-
lands). When labeling for RANKL incubation with a rab-
bit, anti-goat IgG (Cappel; ICN Biochemicals Costa Mesa, 
CA, USA) was used as secondary antibody prior to incuba-
tion with colloidal gold.
Immunofluorescence confocal microscopy
The longitudinal sections of paraffin-embedded femurs 
were rehydrated through a series of graded alcohols, per-
meabilized in 1 % Triton X-100 in TBST for 20 min and 
subsequently blocked with 5 % BSA in TBST for 90 min. 
Primary antibodies were diluted in 1 % BSA, and the sec-
tions incubated over night at 2–8 °C. Co-labeling with rab-
bit anti-TRAP (diluted 1:3,000) and goat anti-OPG (diluted 
1:400) or goat anti-RANKL (diluted 1:400) was performed 
by mixing the primary antibodies before incubation. Non-
specific rabbit and goat IgGs were used as negative con-
trols. After extensive washing, bound primary antibodies 
were visualized by AlexaFluor555 (anti-rabbit) and Alexa-
Flour488 (anti-goat) and counterstained with DAPI nucleic 
acid stain for cell count. Sections were mounted with Dako 
fluorescent-mounting medium (Dako, Denmark) and sealed 
by cover slips before images were obtained using a NIKON 
A1R + confocal laser microscope (Nikon Instruments 
Inc., Melville, NY, USA), equipped with 60 × (water) 
and 100 ×  (oil) immersion lenses. The images were fur-
ther processed by the NIS Elements microscope imaging 
software (Nikon). Double-labeled images were obtained 
by sequential scanning for each channel to eliminate 
the “bleed-through” of the chromophores to ensure reli-
able quantification of the co-localization. Quantification of 
Pearson’s correlation coefficient PCC (Zinchuk et al. 2007) 
above threshold was performed using Coloc2 (ImageJ). 
Strong positive correlation was considered when PCC 
≥0.8. Background subtraction was done by using the built-
in rolling ball radius algorithm and set equal in all images. 
Region of interest (ROI) was selected using lasso tool 
around each cell subjected to analyses. Hypertrophic chon-
drocytes in the growth plate region and diaphyseal osteo-
cytes were analyzed for the two different antibody combi-
nations; TRAP/RANKL and TRAP/OPG. Ten cells from 
each animal and cell type were analyzed and their means 
calculated. The negative controls demonstrated no staining. 
Three-dimensional reconstructions of the confocal section-
ing images (z-stacks) were performed using the Volume 
Viewer plugin (ImageJ).
Immunogold labeling of thawed cryosections
Immunogold labeling of thawed cryosections was per-
formed principally as previously described (Griffiths 1993). 
In brief, for single labeling, sections were incubated with 
1 % BSA in PBS for 30 min at room temperature before 
incubation with primary antibody dissolved in 1 % BSA for 
30 min at room temperature followed by protein A-coated 
5, 10 or 15 nm colloidal gold particles for 30 min at room 
temperature. For double-labeling, sections labeled with 
the first primary antibody and colloidal gold, as described 
for single labeling, were incubated with free protein A in 
1 % BSA for 30 min at room temperature. Before incuba-
tion with the second primary anybody followed by colloi-
dal gold of a different size (for details, see Figure legends), 
both incubations for 30 min at room temperature. Analyses 
were performed using conventional TEM (Tecnai 12, FEI 
Company, Eindhoven, Netherlands).
Measurements of osteocyte canaliculi diameters
The physical limitation for vesicular transport in the osteo-
cyte canaliculi were investigated by measuring the trans-
verse diameter of the osteocyte canaliculi in cortical and 
cancellous bone. After pre-fixation, the paraformaldehyde/
glutaraldehyde long bone specimens were decalcified in 
7 % EDTA with 0.5 % paraformaldehyde before they were 
cut into small samples (~1 mm3) and embedded in con-
ventional epoxy resin. Ultrathin sections (75 nm) were cut 
and mounted on formvar-coated nickel slot grids and sub-
jected to TEM analyses. The diameter of 10 circular cross-
sections of the osteocyte canaliculi were measured for each 
animal in both cortical and cancellous bone, and the results 
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presented as means with standard deviations (SD). The 
statistical analyses were performed in PASW Statistics 18 




Co‑localization of TRAP with RANKL and OPG 
in hypertrophic chondrocytes
Confocal microscopy revealed an intense staining for 
TRAP in hypertrophic chondrocytes in the femur epiphy-
ses. Single labeling for RANKL and OPG displayed a 
similar pattern. Double labeling for TRAP/RANKL and 
TRAP/OPG demonstrated visual co-localization between 
the antibodies in the two pairs. Quantitative co-localization 
analyses for TRAP/RANKL and TRAP/OPG in the hyper-
trophic chondrocytes in the epiphyseal growth plate con-
firmed the visual observed pattern with mean PCC = 0.91 
for TRAP/RANKL and mean PCC = 0.92 for TRAP/OPG 
(Fig. 1). Reconstruction of z-stacks demonstrated co-locali-
zation for the two antibody pairs also in the third dimension 
(Online Resource 1).
Co‑localization of TRAP with RANKL and OPG 
in osteocytes
In the diaphysis, TRAP-positive osteocytes were observed 
clustered in site-specific areas, and the same pattern was 
also observed for RANKL- and OPG-positive osteocytes 
with visual co-localization between TRAP/RANKL and 
TRAP/OPG. However, also other TRAP-positive cells 
were observed; these cells were multinucleated and mainly 
observed at the trabecular surface facing the bone marrow 
and did not label neither for RANKL nor for OPG and were 
judged to be osteoclasts. To confirm the observed pattern of 
co-localization between TRAP/RANKL and TRAP/OPG 
in osteocytes within the bone tissue, quantitative co-local-
ization analyses were performed on the osteocytes that 
demonstrated visual co-localization. Strong co-localiza-
tion was calculated for the two antibody pairs with mean 
PCC = 0.81 for TRAP/RANKL and mean PCC = 0.88 
for TRAP/OPG (Fig. 2). Reconstructions of z-stacks dem-
onstrated co-localization for the two antibody pairs also in 
the third dimension (Online Resource 2). In addition to the 
intracellular co-localization in osteocytes, we also observed 
co-localization of TRAP and OPG in what seemed to be 
osteocyte canaliculi, indicating intracellular transport of the 
proteins in the canaliculi (Fig. 3).
Transmission electron microscopy (TEM)
Morphological features of TRAP + vesicles in osteoblasts 
and osteocytes
TEM analyses showed labeling for TRAP in the Golgi 
complex in osteoclasts and in electron-dense vesicles in 
osteoblasts and osteocytes (Fig. 4a–e). The TRAP + ves-
icles in osteoblasts and osteocytes were 200–500 nm in 
diameter and did not appear to be restricted to any spe-
cific location in the cytoplasm. No fusion between the 
TRAP + vesicles and the cell membrane was observed. 
Monomeric TRAP (loop-TRAP/mTRAP) was detected in 
the Golgi complex in osteoclasts (Fig. 4b, c), but not in 
this organelle in osteoblasts or osteocytes. LAMP1 was 
observed in the vesicular membrane of the TRAP + vesi-
cles in osteoblasts and osteocytes (Fig. 4f, g), indicating 
that the vesicles may represent late endosomes, lysosomes, 
or secretory lysosomes.
Morphological features of RANKL + vesicles 
in osteoblasts and osteocytes
TEM analyses demonstrated RANKL in electron-dense 
vesicles in osteoblasts and osteocytes (Fig. 5a) similar to 
those observed positive for TRAP. These vesicles also dis-
played labeling for LAMP1 in their membranes (Fig. 5b, 
c).
TRAP and RANKL co‑localize in intracellular vesicles 
in osteoblasts and osteocytes
As the observed TRAP + and RANKL + vesicles shared 
similar morphological features as well as presented 
Fig. 1  Co-localization of TRAP with RANKL and OPG in hyper-
trophic chondrocytes. a–d Immunofluorescence images with 
hypertrophic chondrocytes labeled for TRAP (m + cTRAP, red), 
RANKL (green) and the merge of the channels (yellow) as well as 
the merge with DAPI (blue) for cell separation. e–h Immunofluo-
rescence images with hypertrophic chondrocytes labeled for TRAP 
(m + cTRAP, red), OPG (green) and the merge of the channels (yel‑
low) as well as the merge with DAPI (blue) for cell separation. Both 
antibody pairs co-localize in what seem to be vesicular structures in 
the hypertrophic chondrocytes. i, j Unspecific rabbit IgG and goat 
IgG served as negative controls for TRAP and RANKL/OPG, respec-
tively, and did not demonstrate any specific labeling. k Light micro-
scopic image of conventional HES stained corresponding section 
demonstrating the tissue architecture in the epiphysis and metaphysis 
of the distal femur. Light microscopic image of the hypertrophic zone 
in the growth plate at a higher power is inserted. l Pearson’s corre-
lation coefficient (PCC) demonstrated strong co-localization (PCC 
≥0.8) for both TRAP/RANKL and TRAP/OPG in the hypertrophic 
chondrocytes subjected to the co-localization analyses (n = 10 in 
three different animals)
▸
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LAMP1 in their membranes, co-labeling for TRAP with 
RANKL was performed using ultrastructural immunogold 
labeling. This demonstrated co-localization of TRAP and 
RANKL in the vesicles in both osteoblasts and osteocytes 
supporting the results from the confocal laser microscopy 
(Fig. 6a–e).
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Fig. 2  Co-localization of TRAP with RANKL and OPG in diaphyseal 
osteocytes. a–d Immunofluorescence images with diaphyseal osteo-
cytes labeled for TRAP (m + cTRAP, red), RANKL (green) and the 
merge of the channels (yellow) as well as the merge with DAPI (blue) 
for cell separation. e–h Immunofluorescence images with diaphyseal 
osteocytes labeled for TRAP (m + cTRAP, red), OPG (green) and the 
merge of the channels (yellow) as well as the merge with DAPI (blue) 
for cell separation. i, j Unspecific rabbit IgG and goat IgG served as 
negative controls for TRAP and RANKL/OPG, respectively, and did 
not demonstrate any specific labeling. k Light microscopic image of 
conventional HES stained corresponding section demonstrating the tis-
sue architecture of the diaphysis of the femur. Light microscopic image 
of one of the cortices at a higher power is inserted. l Pearson’s correla-
tion coefficient (PCC) demonstrated strong co-localization (PCC ≥0.8) 
for both TRAP/RANKL and TRAP/OPG in the osteocytes subjected to 
the co-localization analyses (n = 10 in three different animals)
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The diameter of the osteocyte canaliculi
The transverse diameter of the osteocyte canaliculi in 
cortical and cancellous bone demonstrated no significant 
difference between the canaliculi diameter in the two 
bone types with means of 219 ± 45 and 236 ± 39 nm 
in cortical and cancellous bone, respectively. The results 
showed little variance with SDs of 20 and 17 %. The 
absolute diameter varied between 147 and 397 nm in cor-
tical bone, and between 159 and 324 nm in cancellous 
bone.
Discussion
This study shows for the first time co-localization of 
TRAP with RANKL in vesicular structures in osteoblasts, 
osteocytes and hypertrophic chondrocytes in vivo, as 
well as co-localization of TRAP with OPG in hyper-
trophic chondrocytes and osteocytes. In addition, LAMP1 
was demonstrated in the membranes of the TRAP + and 
RANKL + compartments.
RANKL is known as one of the key regulators of the 
osteoclastogenesis initiating bone remodeling, while 
OPG is known as the RANKL decoy receptor that inhib-
its the activation of osteoclasts by RANKL and regulates 
bone resorption. RANKL is produced and secreted from 
various types of cells, among them are chondrocytes, 
osteoblasts and osteocytes (Ikeda et al. 2001; Kartsogi-
annis et al. 1999; Kishimoto et al. 2006; Silvestrini et al. 
2005). Recent studies have shown that osteocytes is the 
main source of RANKL in remodeling cancellous bone 
in adult mice (Nakashima et al. 2011; Xiong et al. 2011) 
as well as promoting the bone loss caused by secondary 
Fig. 3  Immunofluorescence images from metaphyseal bone. a TRAP 
(m + cTRAP), red. b OPG, green, with c the merger between the 
channels with co-localization (yellow) between the antibodies in what 
seems to be vesicular structures in osteocyte canaliculi. The image 
along the zx-axis is inserted. d The merger between the channels 
with DAPI (blue) for cell nuclei demonstrates the bony trabecula sur-
rounded by bone marrow. Scale bar 10 µm
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hyperparathyroidism (Xiong et al. 2014). However, the 
exact intracellular mechanisms involved in the regula-
tion and secretion of RANKL are not fully understood, 
although the group of Suzuki has performed extensive 
research on this topic in osteoblasts and osteocytes in vitro 
(Aoki et al. 2010; Honma et al. 2013; Kariya et al. 2009, 
2011). They have demonstrated two pathways for the trans-
port of RANKL to the cell surface in both osteoblasts and 
osteocytes; one minor route transporting RANKL directly 
via the Golgi complex to the cell surface; and one major 
route requiring Vps33a (Kariya et al. 2009) in addition to 
OPG binding to RANKL before the complex is sorted to 
LAMP1 + secretory lysosomes (Aoki et al. 2010). The 
sorting of RANKL to secretory lysosomes in the major 
route seems to be the crucial pathway in the regulation of 
the osteoclastogenesis, as a defect in the traffic regulatory 
activity of OPG increases the osteoclastogenic ability in 
vitro despite increased numbers of OPG decoy receptors 
(Aoki et al. 2010). The release of RANKL through the 
fusion of secretory lysosomes with the plasma membrane 
is suggested to be regulated by the binding of RANK at 
the surface of osteoclast precursors to small amounts of 
RANKL presented at the osteoblast or osteocyte membrane 
from the minor pathway. This will in turn activate Rab27a/b 
and lead to docking and fusion of the secretory lysosomes 
with the plasma membrane and release of RANKL (Honma 
et al. 2013; Kariya et al. 2011). Interestingly, also TRAP is 
sorted into the secretory pathway and lysosomal pathway 
in MDA MB-231 breast cancer cells (Zenger et al. 2010).
LAMP1 is known to be present in membranes of late 
endosomes and lysosomal structures promoting their 
acidic interior and protecting the membranes from auto-
digestion (Fukuda 1991). Generally, late endosomes and 
lysosomes are considered to be degradative organelles 
where lysosomes represent the end-stage of the endocy-
totic route degrading endocytosed material. Different sub-
classes of these organelles, however, do exist and both 
late endosomes and lysosomes can function as secretory 
organelles. Specialized multivesicular late endosomes can 
fuse with the plasma membrane and cause the release of 
exosomes (Raposo and Stoorvogel 2013), and secretory 
lysosomes can secrete their contents in response to external 
stimuli (Holt et al. 2006). Secretory lysosomes and “ordi-
nary” lysosomes share distinct features such as the pres-
ence of lysosomal-associated membrane proteins and 
an acidic luminal pH for the optimal function of the acid 
hydrolases stored in their lumen. Secretory lysosomes are, 
however, specialized as they, in addition to having a deg-
radative function, serve as organelles for storage of newly 
synthesized secretory proteins and possess an ability to 
fuse with the plasma membrane (Blott and Griffiths 2002). 
The presence of LAMP1 in the TRAP + vesicle membrane 
does not alone allow a direct assignment of the nature of 
the vesicles. However, we suggest that the TRAP + vesi-
cles co-labeling for both RANKL and LAMP1 in osteo-
blasts and osteocytes in vivo are similar to the secretory 
lysosomes described as storage compartments for RANKL 
by the group of Suzuki (Aoki et al. 2010). In addition, since 
OPG has been described to regulate traffic of RANKL 
from the Golgi complex to the secretory lysosomes (Aoki 
et al. 2010), this notion is further supported by the immu-
nofluorescence analyses showing strong co-localization 
for both TRAP/RANKL and TRAP/OPG in diaphyseal 
osteocytes. The data may imply a role for TRAP in the 
secretory lysosomes or an extracellular effect of TRAP if 
TRAP is released together with RANKL from the secretory 
lysosomes.
If the vesicles are secretory lysosomes secreting 
their content at the cell surface in order to communicate 
with other cells, e.g., in the bone marrow, they would be 
expected to be small enough to travel along the osteocyte 
canaliculi. In addition, a directional transport mechanism 
should be present. You et al. (2004) have estimated the 
canalicular diameter in various species from other pub-
lications as well as measured osteocyte canaliculi in long 
bone diaphyses from 15 weeks old mice and got variable 
results; the estimated diameter of the osteocyte canaliculi 
varied from 700 nm in human tibia to 100 and 125 nm in 
human compact bone and new born rabbits, respectively. 
In their own results from 15-week old mice, the canaliculi 
diameter varied between 80 and 710 nm. The large varia-
tion may be due to use of different species, sex as well as 
to the measurement techniques; to ensure that the diame-
ter are not measured too small or too wide, only profiles 
with transverse, circular osteocyte canaliculi should be 
measured. In our material, we found the osteocyte canali-
cular diameter to vary between 146 and 397 nm in cortical 
bone and with similar results for cancellous bone and with 
means of 219 and 236 nm, respectively. The diameter of the 
observed TRAP-RANKL-LAMP1 + vesicles varied from 
200 to 500 nm. As the vesicles have lipid membranes, they 
are plastic and may also be able to split to fit into the osteo-
cyte canaliculi, which also varies in size. According to the 
present results, it seems plausible that the vesicles travel 
along the osteocyte extensions to reach the bone surface 
Fig. 4  Micrographs from TEM analyses. a–c Osteoclast in the proxi-
mal tibia metaphysis with double labeling for TRAP (total TRAP), 
10 nm colloidal gold, and loop-TRAP/mTRAP, 15 nm colloidal gold. 
b and c represent the marked areas in a at a higher magnification. d 
Osteoblasts in the proximal tibia metaphysis labeled for total TRAP, 
15 nm colloidal gold. e Osteocyte from tibia diaphysis labeled for 
TRAP (m + cTRAP), 15 nm colloidal gold. f Osteoblasts in proximal 
tibia metaphysis with double labeling for TRAP (total TRAP), 10 nm 
colloidal gold, and LAMP1, 15 nm colloidal gold. g Osteocyte in 
proximal tibia metaphysis with co-labeling for TRAP (m + cTRAP) 
and LAMP1, 5 nm colloidal gold, arrowheads. Scale bars in b, c and 
inserts 100 nm, G Golgi
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or bone remodeling surfaces. One might speculate that the 
actin skeleton (Baik et al. 2013; Murshid et al. 2007) in 
the osteocyte extensions could play a role in a directional 
transport of proteins from the cell body to the bone surface 
equal to the well-studied directional transport along micro-
tubules and actin filaments in neuronal axons and dendrites 
(Hirokawa and Takemura 2005). This would make cell–
cell communication possible and may provide an opportu-
nity for RANK and membrane-bound RANKL to interact 
in order to stimulate osteoclastogenesis. However, further 
investigations on transport mechanisms in osteocytes are 
needed to clarify some of these questions.
The demonstration of loop-TRAP/mTRAP in the Golgi 
complex in osteoclasts but not in osteoblasts and osteocytes 
may be related to a lower synthesis in the latter cells, as a 
low-grade expression is difficult to detect with the immu-
nogold technique. Furthermore, labeling for TRAP in oste-
oblasts and osteocytes was restricted to LAMP1 + elec-
tron-dense vesicles, while no significant labeling was 
observed neither along the synthetic pathway (endoplas-
matic reticulum and Golgi) nor early in the endocytotic 
pathway (plasma membrane, early endosomes, multive-
sicular bodies). This may indicate that the technique is not 
sensitive enough to detect small amounts of protein along 
these pathways and indirectly supports the assumption that 
the observed labeling of TRAP is localized to secretory lys-
osomes where newly synthesized protein gets stored and 
thus concentrated to a degree that allows detection. TRAP 
gene expression in osteoblasts and osteocytes is well docu-
mented by RT-PCR (Kogawa et al. 2013; Qing et al. 2012) 
Fig. 5  Micrographs from TEM analyses. a Tibia diaphysis labeled 
for RANKL, 15 nm colloidal gold, demonstrates labeling in both 
osteoblasts and osteocytes (inserted at a higher power). b Osteo-
blast from proximal tibia metaphysis double-labeled for RANKL, 
15 nm colloidal gold, and LAMP1, 5 nm colloidal gold, arrowheads. 
c Osteocyte from proximal tibia metaphysis with double labeling of 
RANKL, 15 nm colloidal gold, and LAMP1, 5 nm colloidal gold, 
arrowheads. Scale bars in inserts 100 nm
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and in situ hybridization (Gradin et al. 2012; Nakano et al. 
2004). Moreover, osteocytes in both cancellous and corti-
cal bone express loop-TRAP/mTRAP (Solberg et al. 2014), 
and it is therefore not likely that the TRAP + vesicles con-
tain TRAP with another origin than from within the osteo-
blasts and osteocytes themselves. This notion is also sup-
ported by Bonucci et al. (2001).
In addition to the demonstration of TRAP + vesicles 
in osteoblasts and osteocytes, we observed TRAP in what 
seems to be vesicular structures in hypertrophic chondro-
cytes. The presence of TRAP in hypertrophic chondrocytes 
has been reported by others (Hessle et al. 2013). Moreo-
ver, mice lacking TRAP (TRAP –/– mice) present widen-
ing of the epiphyseal growth plates due to a widening of 
the hypertrophic zone with disorganized columns (Blumer 
et al. 2012; Hayman et al. 1996; Hollberg et al. 2002). 
This may reflect disturbed chondrocyte maturation and 
function as well as a defect in the chondroclast/osteoclast 
Fig. 6  Micrographs from TEM analyses. a Osteoblast in proximal 
tibia metaphysis double-labeled for TRAP (m + cTRAP), 10 nm col-
loidal gold, and RANKL, 15 nm colloidal gold. b and c represent the 
marked areas in a at a higher power. d Osteocyte in tibia diaphysis 
double-labeled for TRAP (m + cTRAP), 10 nm colloidal gold, and 
RANKL, 15 nm colloidal gold. e represents the marked area in d at a 
higher magnification
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resorption, indicating a dual effect of the enzyme. RANKL 
has previously been demonstrated in hypertrophic chondro-
cytes (Kishimoto et al. 2006; Silvestrini et al. 2005; Xiong 
et al. 2011) and also reported to be located to the same cell 
type and bone level as OPG (Silvestrini et al. 2005). We 
demonstrate for the first time co-localization of TRAP with 
RANKL and OPG in hypertrophic chondrocytes in what 
seems to be vesicular structures. As hypertrophic chondro-
cytes have been suggested to have a similar function in car-
tilage as osteocytes in bone by initiating remodeling (Xiong 
et al. 2011), we suggest the same mechanisms for TRAP 
in association with RANKL and OPG to be operative in 
hypertrophic chondrocytes as in osteoblasts and osteocytes.
In conclusion, we propose that the vesicular TRAP we 
observe in osteoblasts, osteocytes and hypertrophic chon-
drocytes in relation to RANKL and OPG may either have 
a role intracellularly in secretory lysosomes where the 
enzyme carry out its task in loco as an acidic phosphatase, 
or is secreted in response to external stimuli to perform its 
function extracellularly.
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